Introduction of medical products into healthcare practice and costs reimbursement: European experience

in the present article, we review the ways of introducing medical products into healthcare practice in countries of the european Union and compare them with the Russian experience. in this analysis, we underscore the existing differences but also identify the common aspects, for example, the mandato...

Full description

Bibliographic Details
Main Authors:	V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2018-08-01
Series:	Фармакоэкономика
Subjects:	medical products health technology assessment integrated assessment reimbursement innovations for healthcare clinical and statistical groups
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/252

id	doaj-2655ea6a3f694edeadee2bc63499708f
record_format	Article
spelling	doaj-2655ea6a3f694edeadee2bc63499708f2021-07-28T13:30:40ZrusIRBIS LLCФармакоэкономика2070-49092070-49332018-08-01112596610.17749/2070-4909.2018.11.2.059-066229Introduction of medical products into healthcare practice and costs reimbursement: European experienceV. V. Omelyanovsky0S. S. Otstavnov1N. Z. Musina2V. S. Dombrovskii3Russian Presidential Academy of National Economy and Public Administration, Federal State Educational Institution of Higher Professional Education ; Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution.Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation ; Moscow Institute of Physics and Technology (State University).Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution ; I. M. Sechenov First Moscow State Medical University, Ministry of Health of Russia.Russian Presidential Academy of National Economy and Public Administration, Federal State Educational Institution of Higher Professional Education; Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation.in the present article, we review the ways of introducing medical products into healthcare practice in countries of the european Union and compare them with the Russian experience. in this analysis, we underscore the existing differences but also identify the common aspects, for example, the mandatory stage of integrated assessment; all those are described in detail in the review. The eU experience should be considered when introducing medical products into the healthcare practice in the Russian Federation. The comprehensive assessment of new technologies will provide for the transparency of the proposed system.https://www.pharmacoeconomics.ru/jour/article/view/252medical productshealth technology assessmentintegrated assessmentreimbursementinnovations for healthcareclinical and statistical groups
collection	DOAJ
language	Russian
format	Article
sources	DOAJ
author	V. V. Omelyanovsky S. S. Otstavnov N. Z. Musina V. S. Dombrovskii
spellingShingle	V. V. Omelyanovsky S. S. Otstavnov N. Z. Musina V. S. Dombrovskii Introduction of medical products into healthcare practice and costs reimbursement: European experience Фармакоэкономика medical products health technology assessment integrated assessment reimbursement innovations for healthcare clinical and statistical groups
author_facet	V. V. Omelyanovsky S. S. Otstavnov N. Z. Musina V. S. Dombrovskii
author_sort	V. V. Omelyanovsky
title	Introduction of medical products into healthcare practice and costs reimbursement: European experience
title_short	Introduction of medical products into healthcare practice and costs reimbursement: European experience
title_full	Introduction of medical products into healthcare practice and costs reimbursement: European experience
title_fullStr	Introduction of medical products into healthcare practice and costs reimbursement: European experience
title_full_unstemmed	Introduction of medical products into healthcare practice and costs reimbursement: European experience
title_sort	introduction of medical products into healthcare practice and costs reimbursement: european experience
publisher	IRBIS LLC
series	Фармакоэкономика
issn	2070-4909 2070-4933
publishDate	2018-08-01
description	in the present article, we review the ways of introducing medical products into healthcare practice in countries of the european Union and compare them with the Russian experience. in this analysis, we underscore the existing differences but also identify the common aspects, for example, the mandatory stage of integrated assessment; all those are described in detail in the review. The eU experience should be considered when introducing medical products into the healthcare practice in the Russian Federation. The comprehensive assessment of new technologies will provide for the transparency of the proposed system.
topic	medical products health technology assessment integrated assessment reimbursement innovations for healthcare clinical and statistical groups
url	https://www.pharmacoeconomics.ru/jour/article/view/252
work_keys_str_mv	AT vvomelyanovsky introductionofmedicalproductsintohealthcarepracticeandcostsreimbursementeuropeanexperience AT ssotstavnov introductionofmedicalproductsintohealthcarepracticeandcostsreimbursementeuropeanexperience AT nzmusina introductionofmedicalproductsintohealthcarepracticeandcostsreimbursementeuropeanexperience AT vsdombrovskii introductionofmedicalproductsintohealthcarepracticeandcostsreimbursementeuropeanexperience
_version_	1721273221630656512

Introduction of medical products into healthcare practice and costs reimbursement: European experience

Similar Items